Author:
Hou Weiyu,Hou Weiming,Zhao Xueming
Abstract
AbstractThe study explored the role of circadian rhythm genes (CRGs) in lower grade glioma (LGG) development and found that certain genes, such as CRY1, NPAS2, and RORB, were associated with increased or decreased risk of LGG. The study also investigated the correlation between CRGs and immune cell infiltration, revealing a negative association with macrophage infiltration and a positive correlation with B cell and CD8 + T cell infiltration. Additionally, the study identified major mutated CRGs, including PER2, BMAL1, CLOCK, and BMAL2, and their potential interaction with other CNS-associated genes. The study suggests that CRGs play a crucial role in immune response and tumorigenesis in LGG patients and warrants further investigation.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Aiman, W., Gasalberti, D. P. & Rayi, A. Low-Grade Gliomas. In StatPearls (eds Aiman, W. et al.) (StatPearls Publishing, 2023).
2. Bollinger, T. & Schibler, U. Circadian rhythms—From genes to physiology and disease. Swiss Med. Wkly. 144, w13984 (2014).
3. Petkovic, M., Yalçin, M., Heese, O. & Relógio, A. Differential expression of the circadian clock network correlates with tumour progression in gliomas. BMC Med. Genom. 16, 154 (2023).
4. Lu, D., Zhao, M., Chen, M. & Wu, B. Circadian clock-controlled drug metabolism: Implications for chronotherapeutics. Drug Metab. Dispos. 48, 395–406 (2020).
5. Liu, Y. et al. CRS: A circadian rhythm score model for predicting prognosis and treatment response in cancer patients. J. Transl. Med. 21, 185 (2023).